Recor Medical
Recor Medical raises $125M Series D at $400M valuation
Quick Facts
Recor Medical: Series D Funding Round
Recor Medical has successfully raised $125M in Series D funding, reaching a valuation of $400M.
Company Overview
Renal denervation system for hypertension
Funding Details
The Series D round was led by Deerfield Management, with participation from Boxer Capital, Cormorant Asset Management, Novo Holdings.
Company Information
- Headquarters: 125 Shoreway Road, San Carlos, CA 94070
- Founded: 2009
- Employees: 150+
- Category: MedTech
Investment
Recor Medical plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Deerfield Management: Verified investor in Series D
- Boxer Capital: Verified investor in Series D
- Cormorant Asset Management: Verified investor in Series D
- Novo Holdings: Verified investor in Series D
Key Investors
About the Author
Related Company Reports
Galvenize Therapeutics Raises $100M Series C to Transform MedTech
Galvenize Therapeutics has secured $100M Series C in funding to accelerate growth and innovation in the medtech sector. Medical device company developing pulsed electric field therapies for cardiac ablation and tumor treatment...
Reprieve Cardiovascular Raises $61M Series B to Transform MedTech
Reprieve Cardiovascular has secured $61M Series B in funding to accelerate growth and innovation in the medtech sector. Cardiovascular device company developing personalized heart failure therapies and monitoring solutions...
ViCentra Raises $85M Series D to Transform MedTech
ViCentra has secured $85M Series D in funding to accelerate growth and innovation in the medtech sector. Medical device company developing innovative insulin patch pumps for diabetes management...
